IRIS
BALDANTI, FAUSTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.701
EU - Europa 3.842
AS - Asia 2.229
AF - Africa 15
OC - Oceania 13
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 11.813
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.659
CN - Cina 2.118
IE - Irlanda 1.550
IT - Italia 534
FI - Finlandia 442
UA - Ucraina 392
DE - Germania 300
SE - Svezia 254
GB - Regno Unito 198
FR - Francia 77
IN - India 56
CA - Canada 35
BE - Belgio 31
IR - Iran 18
NL - Olanda 15
RO - Romania 14
JP - Giappone 13
AU - Australia 12
MU - Mauritius 11
RU - Federazione Russa 10
SG - Singapore 8
BR - Brasile 6
CH - Svizzera 6
AT - Austria 5
TR - Turchia 5
EU - Europa 4
GR - Grecia 4
MX - Messico 4
HK - Hong Kong 3
LV - Lettonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
ES - Italia 2
GT - Guatemala 2
IL - Israele 2
KR - Corea 2
MA - Marocco 2
CL - Cile 1
DZ - Algeria 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
ID - Indonesia 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
TW - Taiwan 1
Totale 11.813
Salva come PNG Salva come JPEG
Città #
Dublin 1.529
Chandler 1.314
Ashburn 582
Jacksonville 571
Nanjing 503
Princeton 288
Wilmington 280
Lawrence 257
Helsinki 251
Beijing 238
Nanchang 230
New York 215
Medford 188
Hebei 183
Shanghai 182
Shenyang 170
Changsha 150
Jiaxing 140
Ann Arbor 123
Hangzhou 104
Pavia 103
Milan 97
Tianjin 89
Woodbridge 82
Seattle 76
Boardman 71
Houston 61
Fairfield 56
Los Angeles 56
Pune 46
Washington 42
Norwalk 41
Toronto 29
Brussels 28
Falls Church 26
Rome 22
Verona 19
Jinan 14
Ningbo 14
San Francisco 14
Zhengzhou 14
Redwood City 13
Auburn Hills 12
Taizhou 11
Vicenza 11
Rivoli 10
Timisoara 10
Zanjan 9
Brescia 8
Frankfurt am Main 8
Lecce 8
Tappahannock 8
Turin 8
Borås 7
Cambridge 7
Falkenstein 7
Singapore 7
Des Moines 6
Guangzhou 6
Kunming 6
Taranto 6
Chiavari 5
Como 5
Florence 5
Melbourne 5
Orange 5
Varese 5
Vienna 5
Amsterdam 4
Berlin 4
Corsico 4
Fuzhou 4
Genoa 4
Lodi 4
Manerbio 4
Menlo Park 4
Motta Visconti 4
Redmond 4
Sacramento 4
Spoleto 4
Bologna 3
Boves 3
Bovisio Masciago 3
Cascina 3
Ferrara 3
Ferrara di Monte Baldo 3
Gallarate 3
Laives 3
Legnano 3
Linköping 3
Livorno 3
London 3
Magenta 3
Marcignago 3
Naples 3
Norwich 3
Paris 3
Alghero 2
Andover 2
Basel 2
Totale 8.806
Salva come PNG Salva come JPEG
Nome #
Adoptive transfer of herpesvirus-specific cytotoxic T lymphocytes in transplant recipients 96
Systematic analysis of human oncogenic viruses in colon cancer revealed EBV latency in lymphoid infiltrates. 86
Postinfectious neurologic syndromes: A prospective cohort study 84
Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: Need for mucosal viral load measurement. 80
T-lymphocytes with high proliferative capacity correlate with control of viral suppression in chronically untreated HIV-1 infected individual 80
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. 78
Detection of haemagglutinin D222 polymorphisms in influenza A(H1N1)pdm09-infected patients by ultra-deep pyrosequencing. 76
A new Real-Time RT-PCR Assay for Detection of Human Enterovirus 68 (EV-D68) in Respiratory Samples. 75
Accumulation of defective HIV-1 variants in a patient with slow disease progression. 74
Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation 73
Compartmentalized replication of sars-cov-2 in upper vs. Lower respiratory tract assessed by whole genome quasispecies analysis 73
Diagnosis and counseling of fetal and neonatal HCMV infection. 72
Phylogenetic analysis of HIV type 1 CRF02_AG in multiple genes in Italian and African patients living in Italy. 69
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting. 69
Comparison of three different methods for the evaluation of IL28 and ITPA polymorphisms in patients infected with HCV. 68
Herpes virus-6 chromosomal integration misled the management of Crohn’s disease 68
Colitis in an elderly immunocompetent patient. 68
Viral outbreaks in neonatal intensive care units: what we do not know. 67
Imported hantavirus cardiopulmonary syndrome in an Italian traveller returning from Cuba. 67
A novel human enterovirus C (EV-C118) identified in two children hospitalised because of acute otitis media and community-acquired pneumonia in Israel. 67
Differential outcome of neurological HCMV infection in two hematopoietic stem cell transplant recipients. 67
Human enterovirus and parechovirus infections in newborns with sepsis-like illness and neurological disorders. 67
Persistent human cosavirus infection in lung transplant recipient, Italy. 67
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group. 63
Toward the discovery of novel anti-HIV drugs. Second-generation inhibitors of the cellular ATPase DDX3 with improved anti-HIV activity: synthesis, structure-activity relationship analysis, cytotoxicity studies, and target validation. 63
Frequency of respiratory virus infections and next-generation analysis of influenza A/ H1N1pdm09 dynamics in the lower respiratory tract of patients admitted to the ICU 63
Surveillance and vaccination coverage of measles and rubella in Northern Italy. 62
Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients. 62
Successful in vitro priming of EBV-specific CD8+ T cells endowed with strong cytotoxic function from T cells of EBV-seronegative children 62
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation 62
Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. 61
Novel human enterovirus C infection in child with community-acquired Pneumonia. 61
Circulation of two Enterovirus C105 (EV-C105) lineages in Europe and Africa. 61
Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients 61
Possible role of viral reactivations in the lack of response to conventional therapies in patients with inflammatory bowel disease (IBS) 61
Genome characterisation of enteroviruses 117 and 118: a new group within human enterovirus species C. 61
Letter to the editor. Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. 60
Multiple ganciclovir-resistant strains in a newborn with symptomatic congenital human cytomegalovirus infection. 60
Dissociation between serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus 60
Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemtive therapy in bone marrow transplant recipients 60
Autologous human cytomegalovirus-specific cytotoxic T cells as rescue therapy for ulcerative enteritis in primary immunodeficiency 60
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody. 60
Virtual quantification of influenza A virus load by real-time RT-PCR. 60
Complete genome characterization of enterovirus 104 circulating in Northern Italy shows recombinant origin of the P3 region. 60
Successful medical treatment of EBV smooth muscle tumor in a renal transplant recipient. 59
Kinetics of human cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in international units as determined with the Abbott RealTime CMV assay and an in-house assay. 59
Xenotropic and polytropic murine leukemia virus-related sequences are not detected in the majority of patients with chronic fatigue syndrome. 59
HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients. 59
Maternal, fetal, and neonatal parameters for prognosis and counseling of HCMV congenital infection. 59
Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia. 59
Prospective study of human metapneumovirus infection: diagnosis, typing and virus quantification in nasopharyngeal secretions from pediatric patients. 58
Severe outcome of influenza A/H1N1/09v infection associated with 222G/N polymorphisms in the haemagglutinin: a multicenter study. 58
Reconstruction of the evolutionary dynamics of the A(H1N1)pdm09 influenza virus in Italy during the pandemic and post-pandemic phases. 58
Expanding usutu virus circulation in italy: Detection in the Lazio region, central Italy, 2017 to 2018 58
Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM). 57
Emerging and re-emerging virus infections in neonates and young pediatric patients. 57
Epstein-Barr Virus positive aggressive lymphoma as a consequence of immunosuppression after multiple salvage treatments for follicular lymphoma. 57
Acute cytomegalovirus infection as a cause of venous thromboembolism. 57
Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis. 56
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies 56
Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: towards the next generation HIV-1 inhibitors. 56
Nevirapine-selected mutations Y1811/C of HIV-1 reverse transcriptase confer cross-resistance to stavudine 56
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 56
Multiple clusters of A(H1N1)pdm09 virus circulating in severe cases of influenza during the 2010-2011 season: a phylogenetic and molecular analysis of the neuraminidase gene. 55
Different drug-resistant influenza A(H3N2) variants in two immunocompromised patients treated with oseltamivir during the 2011-2012 influenza season in Italy. 55
Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19 55
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection 55
HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy 54
Authors’ reply: Two severe human cases due to swine influenza a (H1N1)v in October 2016 in Europe were chronologic coincident yet distinct events 53
Comparison of immunologic and molecular assays for the diagnosis of gastrointestinal viral infections. 53
Complete genome sequence of a novel human enterovirus C (HEV-C117) identified in a child with community-acquired pneumonia. 53
Kinetics of Epstein-Barr virus DNA load in different blood compartments of pediatric recipients of T-cell-depleted HLA-haploidentical stem cell transplantation. 52
Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients. 52
Segregation of virulent influenza A(H1N1) variants in the lower respiratory tract of critically ill patients during the 2010-2011 seasonal epidemic 52
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 52
Molecular detection of gastrointestinal viral infections in hospitalized patients. 51
Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients. 51
Detection of Active Epstein-Barr Virus Infection in Duodenal Mucosa of Patients With Refractory Celiac Disease 51
The pentameric complex of human cytomegalovirus: Cell tropism, virus dissemination, immune response and vaccine development 51
T cell therapy of Epstein-Barr virus and adenovirus infections after hemopoietic stem cell transplant 51
Occult HIV infection in a large sample of health-care users in Lombardy, Italy in 2014-2015: Implications for control strategies 51
Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs 50
SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers 50
West Nile Virus Outbreak in the Lombardy Region, Northern Italy, Summer 2013 50
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis 50
Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linted immunospot assay. 49
Zika virus isolation from semen 49
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 49
Enterovirus-D68 (EV-D68) in pediatric patients with respiratory infection: The circulation of a new B3 clade in Italy 49
Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients 48
Chromosomally integrated human herpesvirus 6 in a patient with systemic lupus erythematosus. 48
Usutu Virus Antibodies in Blood Donors and Healthy Forestry Workers in the Lombardy Region, Northern Italy 48
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group. 48
FilmArray® respiratory panel performance in respiratory samples from neonatal care units. 48
Diagnosis and monitoring of human cytomegalovirus infection in transplant recipients 48
Cellular DNA quantification in respiratory samples for the normalization of viral load: a real need? 48
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 48
Monitoring of human cytomegalovirus DNAemia during primary infection in transmitter and non-transmitter mothers 47
12 weeks ombitasvir/paritaprevir–ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis 47
Duration of Zika Viremia in Serum Reply 47
Totale 5.936
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.636
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201921 0 0 0 0 0 0 0 0 0 0 6 15
2019/20202.234 714 941 3 69 1 78 15 77 12 171 148 5
2020/20211.122 94 81 96 72 10 120 52 228 77 145 107 40
2021/20221.251 23 14 27 46 52 29 33 65 72 42 179 669
2022/20234.084 405 278 77 280 328 348 13 203 1.828 41 207 76
2023/20242.227 279 396 101 128 253 598 184 159 29 100 0 0
Totale 12.345